Zanaflex
NDC 83107-001, tizanidine hydrochloride, capsule, from Legacy Pharma USA, Inc..
- Product NDC
- 83107-001
- Status
- Listed
- Labeler
- Legacy Pharma USA, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021447
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83107-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIZANIDINE HYDROCHLORIDE2 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83107-001-15 | 83107000115 | 150 CAPSULE in 1 BOTTLE (83107-001-15) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/60c27d35-7349-4fc6-86ad-70fffdbe3e08
Use it
Look up 83107-001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83107-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83107-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.